Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending July 1
McDonald’s, Dollar Tree, GoFundMe, Stride, Otis, Intrusion, Monogram Health, Mass Luminosity
By
Lauren Muskett
| July 1, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
poison pill
Financial Performance
Finish Line Stock Dives on Earnings Warning
The footwear retailer says Q2 earnings will come in much lower than expected as it adopts an anti-takeover "poison pill."
By
Matthew Heller
| August 29, 2017
Read More
Mergers & Acquisitions
Pier 1 Counters Hedge Fund With Poison Pill
The retailer follows Alden Global's purchase of a 9.5% stake with a plan to protect shareholders from “coercive or unfair” tactics.
By
Matthew Heller
| September 28, 2016
Read More
M&A
Tribune Move May Thwart Gannett Tender Offer
The publisher's board adopts a "poison pill" that could make it too expensive for Gannett to pursue a hostile bid.
By
Katie Kuehner-Hebert
| May 9, 2016
Read More
M&A
How to Talk to Activist Investors
Activist investors are turning up the heat at public companies. It’s up to CFOs to stay cool — and communicative.
By
Keith Button
| May 23, 2014
Read More